choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Avonex

Avonex Newsletter
  • Biogen Commits $2B To Expand US Drug Production Amid Tariff Talk 21 Jul 2025 16:55 GMT

    … Donald Trump. Multiple leading drugmakers committed to investing in … up to 200% on pharmaceutical imports but said companies … and commercial scales. The biotech will also continue to … the facility. Biogen produces Avonex, Plegridy, Tysabri and Qalsody …

  • Taking it in stride: 20 years after her MS diagnosis, marathon runner is as active as ever, thanks to advances in treatment 05 May 2025 01:25 GMT

    … brain,” he says. Early trials of immunomodulators showed they … Ms. Pevec’s first drug, Avonex, was an immunomodulator that had … doctor had more than a dozen other therapies to offer, including pills … MS, and doctors no longer wait to start treatment, Dr. Oh …

  • Harvard Built the Biotech Industry in Cambridge, Then Let It Go. Now It Wants Back In. 25 Apr 2025 10:18 GMT

    … or alpha interferon for cancer treatment. The recombination breakthrough, made by … Biogen successfully developed their first drug — Avonex, used to treat multiple sclerosis … of the biotech industry. Even as essential theoretical and medical research at …

  • MS Drug — Ampyra: A New Gait For Independence 24 Apr 2025 09:03 GMT

    … of Acorda Therapeutics, a biotechnology company based in Hawthorne, … Cooper: The typical MS drugs— the ABCs (Avonex, Betaseron/Betaferon, … the formulation from Elan Pharmaceuticals, which continues to manufacture … access to the treatment. ampyra.com

  • Optum Rx Ends Reauthorization for Many Chronic Disease Drugs 19 Mar 2025 18:04 GMT

    … term condition Requires chronic treatment Long-term drug effectiveness is established … Glatopa, glatiramer acetate, Aubagio, Bafiertam, Avonex, Vumerity, Mitoxantrone, Ampyra, Gilenya, … for procedures and services in Medicare Advantage plans. The healthcare …

  • Avonex Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034 17 Mar 2025 15:38 GMT

    … ), increasing preference for oral medications, heightened patient expectations for … in migration patterns. Avonex is a crucial treatment option, reducing inflammation … ;multiple-sclerosis-drugs-global-market-report Atherosclerosis Drugs Global Market …

  • Avonex: Pregnancy and breastfeeding information 20 Mar 2025 22:30 GMT

    doctor before using this medication. They’ll help determine whether Avonexdoctor or another healthcare professional before taking any medication. The drug … precautions, warnings, drug interactions, allergic … drug does not indicate that the drug or drug

  • Briumvi interactions: Alcohol, medications, and other factors 13 Feb 2025 14:54 GMT

    … 1a (Avonex, Rebif) natalizumab (Tysabri) Steps you or your doctor may take … or symptoms of infection during treatment. Briumvi may have other interactions … your doctor or another healthcare professional before taking any medication. The drug information …

  • Avonex interactions: Alcohol, medications, and other factors 31 Jan 2025 16:48 GMT

    … manufacturer of Avonex did not look at drug interactions in clinical trials. However … cancers. Using Avonex with a monoclonal antibody medication can increase your … certain foods during treatment with Avonex, talk with your doctor. Avonex and vaccines There …

  • Understanding Multiple Sclerosis: Types, symptoms, and treatment options 31 Jan 2025 04:17 GMT

    … ) Visual evoked potentials (VEP) Treatment Medication and therapies can help manage … : Rebif Plegridy Extravia Betaseron Avonex Oral medication for RRMS include: ponesimod … (Gilenya) Intravenous (IV) infusion treatment for RRMS include: Ocrelizumab (Ocrevus …

Satisfied with the content?

Continue to create your account.